Marshall Islands vs Norway: New or unknown treatment history cases: Pulmonary, bacteriologically
Marshall Islands
86
in 2023
Norway
98
in 2023
Marshall Islands rank
160th
Norway rank
158th
New or unknown treatment history cases: Pulmonary, bacteriologically over time
- Marshall Islands
- Norway
How they compare
Norway currently reports 98 against 86 in Marshall Islands, a difference of 12.
That makes Norway's figure about 1.1 times Marshall Islands's.
Across all 11 years both countries report, Norway has been ahead every year.
Marshall Islands ranks 160th and Norway ranks 158th of 197 countries.
Norway has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Marshall Islands | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 62 | 157.71 | 95.71 | Norway |
| 2020s | 43 | 86.75 | 43.75 | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new or unknown treatment history cases: pulmonary, bacteriologically, Marshall Islands or Norway?
- Norway, at 98 against 86 in Marshall Islands as of 2023.
- What is the difference in new or unknown treatment history cases: pulmonary, bacteriologically between Marshall Islands and Norway?
- 12, with Norway ahead.
- How many years of comparable data are there for Marshall Islands and Norway?
- 11 years are reported by both, from 2013 to 2023.
- How do Marshall Islands and Norway rank globally for new or unknown treatment history cases: pulmonary, bacteriologically?
- Marshall Islands ranks 160th and Norway ranks 158th of 197 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New or unknown treatment history cases: Pulmonary, bacteriologically confirmed. Statizoid refreshes it automatically from the source and publishes the full history for both places.